Pharmaceutical characterization of amoxicillin trihydrate as mucoadhesive microspheres in management of H. pylori

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 348-358

  Singh, S K ^a   Chidrawar, V R ^a   Ushir, Y V ^a   Vadalia, K R ^a   Sheth, N R ^b   Singh, S ^c  

^a Shree H N Shukla Institute of Pharmaceutical Education and Research   (India)

^b SAURASHTRA UNIVERSITY   (India)

^c CPS Mahuda College of Pharmaceiutical Sciences   (India)

Author keywords

Amoxicillin trihydrate; Gastric residence time; Mucoadhesive microsphere

Indexed keywords

AMOXICILLIN; MICROSPHERE;

ARTICLE; DRUG FORMULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MUCOADHESION; NONHUMAN; SUSTAINED DRUG RELEASE;

EID: 77953406178     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Suleymanlar I., et al. Response to triple treatment with omeprazole, amoxicillin trihydrate and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients, Adv. Perit. Dial, 1999, 15, 79-81.
2. Vakil N. and Cutler A., Ten-day triple therapy with ranitidine, bismuthcitrate, amoxicillin trihydrate and clarithromycin in eradicating Helicobacter pylori, Am. J. Gastroenterol, 1999, 94 (5), 1197-1199.
3. Buzas G.M. and Szekely E., Eradication of Helicobacter pylori in peptic ulcer patients, Orv. Hetil 1999, 140 (3), 121-124.
4. Lin C.K., Hsu P.I. and Lai K.H., One-week quadruple therapy is an effective salvage regimen for Helicobactere pylori infection in patients after failure of standard triple therapy, J. Clin. Gastroenterol, 2002, 34 (5), 547-551.
5. Kawabami E., Ogata S.K. and Portorreal A.C., Triple therapy with clarithromycin, amoxicillin trihydrate and omeprazole for Helicobacter pylori eradication in children and adolescents. Arq. Gastroenterol 2001, 38 (3), 203-206.
6. Cooreman M.P, Krausgrill V. and Hengels K.J., Local gastric and serum amoxycillin concentrations after different oral application forms, Antimicrobial Agents Chemotherapy, 1993, 37, 1506-1509.
7. Atherton J.C, Cockayne V., Balsitis M., Kirk G.E., Hawley C.J. and Spiller R.C., Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxicillin trihydrate and cimetidine, Gut, 1995, 36, 670-674.
8. Axon A.T., The role of acid inhibition in the treatment of H. pylori. Infection. Scand., J. Gastroenterol, 1994, 29, 16-23.
9. Giacomo F., Mariano L., Silvana M., Domenico S., and Gaetano G., Amoxicillin trihydrate-loaded polyethylcyanoacrylate nanoparticles: influence PEG coating on the particle size, drug release rate and phagocytic uptake, Biomaterials, 2001, 22, 2857-2865.
10. Hilton A.K. and Deasy P.B., In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihydrate, Int. J. Pharm, 1992, 86, 79-88.
11. Chen C.J, Jacob J., Klein A.B, Chayapruks T. and Mathiowitz E., Bioadhesive polymers for stomach targeted drug delivery, Proceedings 24th International Symposium on Controlled Release of Bioactive Materials. Stockholm 1997, 259-260.
12. Nagahara N., Akiyama Y., Nakao M., Tada M., Kitano M. and Ogawa Y. Mucoadhesive microspheres containing amoxicillin trihydrate for clearance of H. pylori. Antimicrob. Agents Chemother 1998, 42 (10), 2492-2494.
13. Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y and Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv 2000, 7 (4), 237-243.
14. Clausen AE and Bernkop-Schnurch A. Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery, J. Control. Release, 2001, 75 (1-2), 93-102.
15. Cuna M., Alonso M.J. and Torres D., Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxicillin-resin complexes for drug delivery to the gastric mucosa, Eur. J. Pharm. Biopharm, 2001, 51, 199-205.
16. Bogataj M., Mrhar A., Kristl A. and Kozjek F., Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods, J. Microenacapsul, 1991, 8, 401-406.
17. Arul B., Kothai R. and Sangameswaran B. et al., Formulation and evaluation of micro spheres containing isoniazid, Indian Journal of Pharmaceutical Science ,2003, 65, 640-642.
18. Raghavendra C. Mundargi et al., Formulation and in-vitro evaluation of noval starch-based tableted microsphere for controlled release of amplicillin, Carbohydrate polymer, 2008, 71, 42-53.
19. Lehr CM, Bowstra JA, Tukker JJ and Junginer HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. Journal of Controlled Release 1990, 13, 51-62.
20. Zhepeng Liua, Weiyue Lua, Lisheng and Qianb et al., In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin, Journal of Controlled Release, 2005, 2, 135-144.
21. Paulo Costa and Jose Manuel Sousa Lobo. Modeling and comparison of dissolution profiles, European Journal of Pharmaceutical Sciences, 2001, 13, 123-133.